April 29, 2013 – A request has been filed to consolidate all Lipitor type 2 diabetes lawsuits filed on the federal level into a multidistrict litigation (MDL) for pretrial handling before a single judge. The motion for consolidation is intended to reduce duplicative discovery, avoid conflicting rulings by different judges, and to speed things through the litigation process as quickly as possible. In addition to being linked to type 2 diabetes, Lipitor has also recently been associated with muscle damage, myopathy, kidney damage / failure, liver failure, rhabdomyolysis, memory loss, and death.
Free Lipitor and Type 2 Diabetes Lawsuit Evaluation: If you or a loved one was diagnosed with type 2 diabetes after taking Lipitor, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Lipitor and we can help.
What’s the Problem?
The request to consolidate the federal Lipitor type 2 diabetes lawsuits was submitted to the U.S. Judicial Panel on Multidistrict Litigation (JPML) on April 26 by a group of plaintiffs who have filed product liability claims against Pfizer. To date, at least five different Lipitor lawsuits have been filed in three different district courts this year, and the motion indicates that given how widely prescribed the drug is around the country, many more similar complaints are expected in the coming weeks and months. The requests seeks consolidation in the U.S. District Court for the District of South Carolina.
Manufactured and marketed by pharmaceutical giant Pfizer & Co., Lipitor is one of the best-selling mediations on the planet, with millions of patients receiving the drug to lower cholesterol levels and reduce the risk of heart disease. The drug belongs to a class of medications known as statins, which generate nearly $15 billion in combined sales each and every year. In February 2012, Pfizer updated Lipitor warning labels with language indicating that, for the first time, the drug had been linked to type 2 diabetes or changes in blood sugar levels.
Around the country, a growing number of women have filed lawsuits against Pfizer, alleging that the company withheld information about Lipitor’s ability to cause type 2 diabetes, even though it appears that this potential complication has been known for some time. Complaints allege that otherwise healthy women took Lipitor and subsequently developed diabetes, which requires regular blood sugar testing, restrictive diets, and the need for additional prescription drugs to control the condition. As a result of complications associated with diabetes, plaintiffs also claim they now face an increased risk of heart disease, blindness, neuropathy, kidney disease and other problems.
“Because of the common issues of fact and the number of current and anticipated claims, these cases are well suited for transfer and pretrial consolidation,” according to arguments raised in the MDL petition. The JPML is expected to hear oral arguments over the potential Lipitor diabetes consolidation at an upcoming hearing on July 25, in Portland, Maine.
Do I Have a Lipitor Type 2 Diabetes Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lipitor lawsuits. We are handling individual litigation nationwide and currently accepting new Lipitor type 2 diabetes cases in all 50 states.
Free Lipitor and Type 2 Diabetes Lawsuit Evaluation: If you or a loved one was diagnosed with type 2 diabetes after taking Lipitor, you should contact our law firm immediately. You may be entitled to compensation by filing a Lipitor type 2 diabetes suit and we can help.